REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/14/2025
Back to search
Official data from USPTO
CELLESTIA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CELLESTIA
ST13
US500000079246636Class
1, 5, 42
Filing
79246636
Registration
6098248
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
07/15/2025
Trademark type
Word
Nice classes
1, 5, 42
Filing date
11/01/2018
Registration date
07/14/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/14/2020
Last transaction
07/15/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
CH
Examiner
EISNACH, MICHAEL
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Cellestia Biotech AG
Representatives
Anthony E. Bennett HOFFMANN & BARON, LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical products for use in industry and sciencechemicals for use in the manufacture of pharmaceutical and veterinary products; Chemicals for use in biotechnological product development
Class 5
Pharmaceutical and veterinary productsfor the treatment of cancer and for regenerative medicine; pharmaceutical preparations for the treatment of cancerleukemialymphomainflammatory diseasesliver diseaseslung diseasescardio diseasesvascular diseasesgenetic disorders and immunity disorders; pharmaceutical productsnamely small molecule drugs for the treatment of cancer; pharmaceutical products for the treatment of NOTCH-dependent cancers; medicinal preparations for the treatment of cancerleukemialymphomainflammatory diseasesliver diseaseslung diseasescardio diseasesvascular diseasesgenetic disorders and immunity disorders; veterinary medicines for the treatment of cancerleukemialymphomainflammatory diseasesliver diseaseslung diseasescardio diseasesvascular diseasesgenetic disorders and immunity disorders; chemical and pharmaceutical preparations for the treatment of cancerleukemialymphomainflammatory diseasesliver diseaseslung diseasescardio diseasesvascular diseasesgenetic disorders and immunity disorders; diagnostic preparations for medical use; chemical and pharmaceutical preparations for veterinary use for the treatment of cancerleukemialymphomainflammatory diseasesliver diseaseslung diseasescardio diseasesvascular diseasesgenetic disorders and immunity disorders
Class 42
Scientific and technological servicesscientific research and development in the field of pharmaceuticals; researchdevelopment of products and quality control in the field of pharmacy; research in the field of chemistry and biology; industrial analysis and research services in the field of pharmaceuticals; research and development of pharmaceutical and veterinary products; chemical analysis and research in the field of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
36 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/21/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/03/2020
FIMP
FINAL DISPOSITION PROCESSED
11/03/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/14/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
07/14/2020
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
06/04/2020
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/15/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/29/2020
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/29/2020
CHPB
POST PUBLICATION AMENDMENT - ENTERED
03/26/2020
APET
ASSIGNED TO PETITION STAFF
03/25/2020
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
02/24/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/24/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/24/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/24/2020
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
10/22/2019
GPNX
NOTIFICATION PROCESSED BY IB
10/05/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/24/2019
PUBO
PUBLISHED FOR OPPOSITION
09/24/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/18/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/18/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/04/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/19/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/17/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/16/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/16/2019
RFNP
REFUSAL PROCESSED BY IB
03/08/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/20/2019
RFRR
REFUSAL PROCESSED BY MPU
02/20/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/08/2019
CNRT
NON-FINAL ACTION WRITTEN
02/07/2019
DOCK
ASSIGNED TO EXAMINER
02/07/2019
MAFR
APPLICATION FILING RECEIPT MAILED
12/04/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/30/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/29/2018
Continuous trademark protection
Get notified about every new filing that threatens CELLESTIA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.